Bipolar affective disorder is a genetically complex psychiatric disorder with a population prevalence of approximately 1%. We have previously reported cosegregation of bipolar affective disorder and Darier's disease, a dominant skin disorder with a neuropsychiatric component. The gene for Darier's disease was mapped to chromosome 12q23-q24.1 and linkage studies by us and others have subsequently implicated this region as harbouring a susceptibility gene for bipolar affective disorder. In this study we have investigated the Darier's disease gene ATP2A2, the calcium pumping ATPase SERCA2, as a potential susceptibility gene for bipolar disorder under the hypothesis that variations in SERCA2 have pleiotropic effects in brain. Support for this hypothesis comes from clinical evidence of neuropsychiatric abnormalities in Darier's disease, genetic data produced in our study showing non-random clustering of missense mutations in ATP2A2 in neuropsychiatric Darier patients, and functional data demonstrating the role of SERCA2 in intracellular calcium regulation. In a panel of 15 unrelated bipolar patients from multiply affected families showing increased allele sharing at markers in the 12q23-q24.1 region, we performed mutational screening of the ATP2A2 coding sequence, promoter regions, and 3Ј untranslated region and identified six sequence variations. These were analysed in a large sample of bipolar patients (n ‫؍‬ 324) and control subjects (n ‫؍‬ 327). Analysis of allele and genotype distributions for all six variations, and of haplotype frequencies showed no evidence for the involvement of ATP2A2 in producing susceptibility to bipolar disorder. Molecular Psychiatry (2001) 6, 92-97.
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There is now firm evidence from family, twin, and adoption studies for the involvement of genetic factors in the pathogenesis of bipolar affective disorder (BPD). 1 Although there may be a small number of families where major genes are involved, the mode of inheritance is generally complex and non-mendelian, 2 and the identification of susceptibility loci is, therefore, difficult.
Evidence for the existence of a susceptibility gene for BPD on chromosome 12q first came to light in 1993 when we described a family (pedigree 324) cosegregating Darier's disease, a dominant skin disorder, and major affective disorder. 3 We proposed that the observed cosegregation could be due to genetic linkage (max lod ϭ 2.11) between the Darier's disease gene and the BPD susceptibility locus. We have since identified another Caucasian family of European origin (pedigree 5501) in which there is co-occurrence of Darier's disease and major affective disorder. 4 The gene for Darier's disease was mapped to chromosome 12q23-q24.1. [5] [6] [7] [8] [9] In a subsequent linkage study of 45 European BPD families (excluding pedigree 324) we found suggestive evidence for linkage to chromosome 12q23-q24.1.
10 Most significant evidence was found in the Cardiff-based subset of families suspected to be most genetically similar to pedigree 324 (max lod ϭ 1.65) This finding has since been replicated, most significantly by Barden et al 11 who derived a lod score of 4.9 in an extended family from Québec, and by Ewald et al 12 who analysed two Danish families and found a maximum lod score of 3.37.
A parsimonious explanation for the findings described above would be pleiotropy. This possibility is consistent with the observation that skin and brain tissue share common ectodermal embryonic origins 3 and finds support in evidence from clinical, genetic, and functional studies.
Clinical evidence
In the presence of pleiotropy, a population level association between Darier and neuropsychiatric phenotypes would be expected. Although robust epidemiological data are lacking, available data are consistent with this possibility: clinical experience suggests that diverse neuropsychiatric abnormalities are relatively common in Darier's disease and there have been frequent reports of association with several neuropsychiatric disturbances, particularly mood disorders, 3, [13] [14] [15] [16] [17] [18] [19] suicidal ideation and behaviour, 17, 20, 21 epilepsy, 15 and mental retardation. 16, 20, 22 Genetic evidence The gene for Darier's disease has recently been identified as ATP2A2 and a variety of missense, nonsense, frameshift, and splicing mutations in this gene have been described in families with Darier's disease. [23] [24] [25] [26] This gene encodes the sarco(endo)plasmic reticulum calcium pumping ATPase SERCA2, which has a central role in intracellular calcium signalling. 27 This type of pump couples ATP hydrolysis with the transport of calcium ions from the cytosol into the sarcoplasmic/ endoplasmic reticulum, thus regulating cytosolic calcium concentrations. 28, 29 SERCA2 is expressed in many cell types including neurones. 30 Genetic support for the pleiotropy hypothesis has come from our mutational analysis studies of ATP2A2. We found a predominance of missense mutations clustered in the 3Ј half of the gene in patients with neuropsychiatric phenotypes and Darier's disease, when compared to patients with Darier's disease alone. Particularly interesting was our finding that two unrelated Darier patients who had clinical features of bipolar spectrum mood disorder had the same missense mutation within the ATP binding domain, suggesting that this domain may play a role in mood disorder. 26 
Functional evidence
The SERCA2 molecule consists of a number of functional domains, a calcium binding domain (stalk region) consisting of five ␣-helices, a ␤-strand domain, a nucleotide binding domain, a phosphorylation domain, a hinge domain, and a transmembrane domain consisting of ten ␣-helices in the case of SERCA2a and a potential eleventh ␣-helix in SERCA2b, that form the sides of the ion channel lumen. There are four known mRNA isoforms which differ in the structure of their 3Ј untranslated regions. The class 1 mRNA (SERCA2a protein isoform) is expressed in muscle tissue, class 2 and 3 mRNAs are expressed in non-muscle and nonneuronal cells, and the class 4 mRNA is expressed exclusively in the brain. 31 The ATP2A2 gene spans 76 kb of genomic DNA and consists of 21 coding exons 23 and four 3Ј UTR exons. 31 The known function of the SERCA2 protein lends support to a possible role in BPD. Intracellular calcium signalling in neurones is involved in neuronal excitability, neurotransmission and synaptic plasticity. 32 There are a number of lines of evidence that suggest defects in calcium homeostasis may play a significant role in BPD. It has been shown that there is an increase in intracellular calcium concentration in the lymphocytes and platelets of patients with BPDI disorder when compared to other patients with mood disorders, and control subjects. 33 Moreover, drugs used for the treatment of BPD, for example lamotrigine 34 and verapamil 35 are thought to elicit their effects through alterations in intracellular calcium. Finally, lithium, used as a treatment for BPD, has been found to regulate the phosphoinositide (PI) second messenger signalling pathway [36] [37] [38] [39] leading to changes in intracellular calcium concentration, distribution, and signalling. 40 As we have outlined, ATP2A2, the causative gene of Darier's disease is a positional and functional candidate susceptibility gene for BPD. In this study we have investigated the possibility that variation in the coding sequence, promoter regions or the 3Ј untranslated region of this gene influences susceptibility to BPD.
Molecular Psychiatry
We identified six sequence variations in the screening set of 15 bipolar probands. Three transitions and one transversion were identified within the ATP2A2 coding sequence but all were synonymous at the amino acid level. One transition was identified in intron 3 and another identified 5Ј to the start of transcription in an area containing putative upstream transcription control elements. 41 Assays were developed for each variation (Table 1) . These assays were utilised to analyse the entire sample of probands and controls except −2549G→A and 87C→T which were analysed in a subsample of 218 BPD patients, and 218 controls. The data produced for each polymorphism can be found in Table 2 (note that minor differences in sample sizes were due to PCR drop-out). We compared genotype and allele frequencies for each polymorphism, separately, between patients and controls and found no significant association of any allele or genotype for any of the six polymorphisms with disease state. We compared haplotype frequencies between the sample groups and found no significant association of any haplotype with BPD. We also compared the patient and control samples for the presence of polymorphism per se and found no significant differences between groups (P ϭ 0.801).
In summary, we performed mutational analysis on ATP2A2, the causative gene for Darier's disease, as a positional and functional candidate susceptibility gene for bipolar affective disorder. After screening of the coding sequence, promoter regions, and 3Ј untranslated region, six sequence variations were identified. Four variations were within the coding region but were synonymous at the amino acid level, one variation was identified in intron 3, and one was identified in the region 5Ј to the start of transcription in an area known to contain promoter elements. 41 Sequence variation 87C→T was found only once in the patient sample and 2697G→T was found three times in the patient sample. Although these exonic variations were synonymous at the amino acid level it is possible that they could produce changes in mRNA decay times, or structure. 42 However, in the absence of RNA samples for the appropriate patients we were not able to verify this.
All sequence variations were analysed using RFLP assays in a large sample of bipolar probands, and control subjects. We compared genotype, and allele frequencies for each polymorphism, and haplotypes involving all six polymorphisms between the proband group and control group. No significant differences were found for any polymorphism, when analysed separately, nor for haplotypes between the two sample groups. No significant differences were found between the two groups when analysed for the presence of polymorphism per se. Neither did we find evidence that the patients with polymorphisms differed phenotypically from those who did not. All the polymorphisms identified were rare (most common frequency 7%) and our data gave no indication that ATP2A2 is involved in producing susceptibility to BPD. Any negative study must be interpreted within the context of its power to detect an effect if it were present. For the current study we need to consider three issues: (a) Sensitivity of DHPLC. Employing DHPLC as a detection method using both recommended DNA strand melting temperatures (RT m ) and RT m ϩ 2°C, we were confident of a near 100% detection efficiency. 43 (b) Power to identify a polymorphism in the screening sample. Simple consideration of the binomial distribution shows that our screening sample of 15 individuals gave 95% power to detect a polymorphism of frequency above 10% and a power greater than 80% to detect polymorphisms of frequency greater than 5%. Moreover, this consisted of affected cases from families showing positive lod scores with markers from the Darier's region. 10 (c) Power to detect an allelic association with disease. Using a test size (critical P value) of 0.05 our study has power Ͼ80% to detect associations with an odds ratio greater than or equal to 1.8 for the 2172G→A polymorphism although, as expected, the power is lower for rarer polymorphisms. Thus, taking into account these power calculations, we can be confident that there are no common polymorphisms in this gene that make an important contribution to susceptibility to BPD within the population studied.
Our data do not provide support for the suggestion that SERCA2 is commonly involved in susceptibility to BPD. It remains possible that susceptibility is conferred by other, as yet, undetected polymorphisms or that rare variants make a major contribution to susceptibility in occasional families.
In conclusion, we propose that the cosegregation of BPD and Darier's disease observed in pedigree 324 3 and pedigree 5501 4 is likely to be due to linkage of distinct genes, rather than being a pleiotropic effect of ATP2A2. We are continuing our search for the BPD susceptibility gene in this region using a combination of linkage disequilibrium and candidate gene approaches. In contrast, we believe it likely that the common co-occurrence in unrelated subjects of Darier's disease and other neuropsychiatric phenotypes is due to pleiotropic effects at ATP2A2. Functional consequences of mutations identified by us in Darier's disease patients with neuropsychiatric phenotypes 26 are currently being investigated.
Materials and methods

Bipolar probands
UK Caucasian subjects with DSM-IV 44 Bipolar I disorder (n ϭ 324, mean age 47 Ϯ 26 SD, 58% female), were recruited from outpatient clinics in Wales and the Midlands of England. Probands were all interviewed by a trained psychiatrist using either SADS-L (Schedule for Affective Disorders and Schizophrenia, Lifetime Version) 45 modified to provide diagnostic information for DSM-IV or by the Schedule for Clinical Assessment in Neuropsychiatry (SCAN), 46 and hospital records were obtained. Best estimate lifetime diagnoses were made upon the basis of all available clinical data.
Control subjects
Unrelated British Caucasian comparison individuals, who were not screened to exclude subjects with a history of psychiatric illness, were recruited from the Blood Transfusion Service in South Wales (Group 1: n ϭ 218, mean age 44 Ϯ 10 SD, 58% female) or were patients attending a family medical practitioner in South Wales for non-psychiatric reasons (Group 2: n ϭ 109, mean age 48 Ϯ 18 SD, 65% female). Ethical approval was obtained for the study and all subjects provided written informed consent to participate in genetic studies.
Cases used for polymorphism/mutation detection
Fifteen DSM-IV Bipolar I probands in the above sample came from families who showed increased allele sharing with markers in the 12q23-q24.1 region in our linkage study. 10 These individuals were utilised for the polymorphism/mutation analysis studies described below.
PCR amplification of ATP2A2 coding sequence, promoter region and 3Ј untranslated region
The ATP2A2 genomic DNA sequence was obtained from Sakuntabhai et al 23 and by alignment of the cDNA sequences for ATP2A2a (SERCA2a) and ATP2A2b (SERCA2b) (accession numbers M23114 and M23115) to the Genbank database using the BLAST program at the National Centre for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST/). Precise locations of each exon within the PAC clone 305I20 were noted and the appropriate section of genomic sequence utilised for primer design. The ATP2A2 promoter region has been well characterised 41 and promoter sequences were identified within PAC 305I20 and appropriate sections utilised for primer design. The maximum extent of the 3Ј untranslated region was identified as a 5-kb sequence (approximately) within 305I20 with reference to ATP2A2b sequence M23114 which contains exon 22, the most upstream 3Ј UTR exon, and the ATP2A2a sequence M23115 which contains exon 25, the most downstream 3Ј UTR exon. 31 Oligonucleotide primers for PCR assays were designed for each DNA fragment under analysis. In some cases coding exons were split into two pieces with sufficient overlap. Promoter and 3Ј UTR fragments were designed to overlap sufficiently. PCR primers were designed using the Primer3 program based at the Whitehead Institute Centre for Genome Research (http://www-genome.wi.mit.edu/cgi-bin/primer/primer3.cgi).
PCR analysis was carried out on high molecular weight genomic DNA isolated from lymphocytes or 
Denaturing high performance liquid chromatography (DHPLC) analysis of PCR-amplified products
Mutation detection was performed using denaturing high performance liquid chromatography (DHPLC). 47, 48 In essence, the method depends upon detecting heteroduplexes in PCR products by high performance liquid chromatography. Sensitivity of the analysis is maximised by maintaining the HPLC column at a temperature that favours partial strand denaturation in the presence of base pair mismatching. Optimal temperature for the analysis was selected using DHPLCMelt (written by P Oefner and N Hansen, available at http://insertion.stanford.edu/melt.html). We have previously shown that the DHPLCMelt recommended temperature (RT m ) supplemented by an extra run at 2°C above the RT m predicts DHPLC conditions that detect 103/103 mutations in blind analysis. 43 After PCR amplification, heteroduplexes were given the opportunity to form by heating the products to 95°C for 5 min and then cooling to 65°C over 30 min. DHPLC analysis was performed at the RT m using a WAVE DHPLC system (Transgenomic, CA, USA) and a DNASep column (Transgenomic) using a linear triethylammonium acetate/acetonitrile gradient.
DNA sequencing
Sequencing reactions were carried out on samples showing heteroduplexes upon DHPLC analysis. Sequencing analyses were performed on both strands of double-stranded PCR products using the appropriate forward and reverse PCR primers. Radioactive DNA cycle sequencing was performed using the Thermosequenase kit (Amersham, Bucks, UK) according to the manufacturer's instructions.
Restriction fragment length polymorphism (RFLP)
analysis DNA sequence analysis was performed using the Lasergene DNAstar program. DNA sequence variations identified were analysed in the proband and control sample by utilising restriction endonucleases whose sites were either created or inactivated by the sequence variations observed. In the case of the −2549G→A polymorphism, a modified RFLP assay was developed using the approach employed by Arinami et al. 49 We verified that DHPLC profiles scored for the DHPLC screening sample subset concurred with the RFLP pat-terns observed. Details of the polymorphisms and enzymes employed for their analysis can be seen in Table 1 .
Statistical analysis
Departure from Hardy-Weinberg equilibrium was tested using a 2 goodness-of-fit test. Statistical significance of differences between allele distributions was assessed using 2 tests. For genotype distributions some cells in contingency tables had expected values below 5. In order to assess the statistical significance of genotype distributions we therefore used a MonteCarlo method as implemented in CLUMP. 50 This determines a P value by estimating by simulation the proportion of times the observed 2 for the contingency table might be expected to occur by chance, conditional on the marginal totals of the table.
Maximum likelihood multi-marker relative risk (ie haplotype) analyses were undertaken using the computer programme HAPMAX (http://www.uwcm.ac.uk/ uwcm/mg/download) (Krawczak, 1988) . This programme employs the EM algorithm to make efficient use of phase unknown data.
